Navigation Links
Inflazyme Announces Outcome of Review of Phase 2b Asthma Study:,Potential Mitigating Factors Identified which Prevent Clear,Interpretation of Results

RICHMOND, British Columbia, March 12, 2007--Inflazyme Pharmaceuticals Ltd. (TSX: IZP). As announced on January 29, 2007, the preliminary results of the Phase 2b CAPSICS study with IPL512,602 showed no statistical or clinical difference between patients who received drug or placebo. However, the placebo response was surprisingly large and consistent across a number of the end-points, which prompted an examination by Inflazyme and its external experts to determine if anything untoward had occurred during the study.

To put the placebo response in perspective, we compared the results of our study to publications of other asthma clinical studies where Asthma Quality of Life was used as an endpoint. Our placebo response was two to three times greater than generally observed. Dr. William Busse and Dr. Mark FitzGerald, two leading clinical asthma experts who reviewed the data, agreed that "the large magnitude of the placebo response is surprising and could potentially obscure any apparent benefits of IPL512,602".

Our medical advisors have offered three possible factors contributing to the high placebo response. First, as is not uncommon, the study did not include placebo treatment during the run-in period at the start of the trial when patients were to be stabilized on their existing therapy. Observing a large placebo effect during this run-in period could have excluded those patients from the study.

Second, subjects were on a background therapy of inhaled corticosteroids and it is not possible to determine if there may have been compliance issues whereby patients were not taking their medications on a consistent basis as prescribed in the run-up to the study. A part of the placebo response might indeed be attributable to patients, once enrolled into the study, paying more attention to their symptoms and becoming more compliant with their background medications.This may have resulted in an improvem
'"/>




Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:9/17/2014)... , Sept. 17, 2014   OTEMR, Inc. , ... Complete EHR certification, which designates that the software is ... 1 and Stage 2 Meaningful Use measures required to ... Act (ARRA).  ONETOUCH EMR 2.0 was certified on July ... of the National Coordinator-Authorized Certification Body (ONC-ACB) and is ...
(Date:9/17/2014)... , Sept. 17, 2014  Millions of people suffer from ... disease. Recently the FDA approved the launch ... an innovative implant device developed by Spinal Kinetics, which may ... neck and or arm pain. Hospital for Special Surgery (HSS), ... only hospital in New York City ...
(Date:9/17/2014)... , Sept. 17, 2014   MedeAnalytics ... solution that brings complete visibility to a provider,s ... an ever-evolving reimbursement landscape. Powered by the industry,s ... to the critical point between patient access and ... The solution will improve revenue capture, minimize audit ...
Breaking Medicine Technology:OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 2OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 3Cervical Disc Clinical Trial for People with Neck and Arm Pain Set to Begin at Hospital for Special Surgery 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 3
... on 11 Patients at SAWCPRINCETON, N.J., April 29 ... (OTC Bulletin Board: DSCI), a provider of advanced wound ... the Advances in Wound Care (SAWC) in Dallas, Jason R. ... Florida, revealed details of a recently concluded 11-patient venous leg ...
... to Cover Therapeutic Delivery Across Blood-Brain BarrierNOVATO, Calif., ... ("Raptor" or the "Company") (OTC Bulletin Board: RPTP) ... Trademark Office ("USPTO") has issued two Notices of ... 11/202,566, titled " Methods of increasing delivery of ...
Cached Medicine Technology:Clinician Reports Fast Healing of Intractable Wounds Using MEDIHONEY(R) 2Clinician Reports Fast Healing of Intractable Wounds Using MEDIHONEY(R) 3Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications 2Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications 3Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications 4Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications 5
(Date:9/17/2014)... Buffers that guard against damage to the ends of chromosomes ... melanoma the deadliest form of skin cancer according ... The study has uncovered an important new genetic risk factor ... mole count are the strongest indicators of those most at ... more care in the sun, as they burn more easily. ...
(Date:9/17/2014)... Chicago IL (PRWEB) September 17, 2014 ... of Pseudomonas aeruginosa infections allegedly caused by Non-Sterile ... to learn more about their options for legal recourse. ... & Drug Administration (FDA) in March 2012, after the ... Pseudomonas aeruginosa at William Beaumont Hospital in Royal Oak, ...
(Date:9/17/2014)... NY (PRWEB) September 17, 2014 In ... acknowledges that “bi-weekly telephonic discovery conferences would be beneficial ... such conferences through mid-December. “At the end of December,” ... assess the need for additional conferences. , “The ... recognizes that there is still much to be discussed ...
(Date:9/17/2014)... News, VA (PRWEB) September 17, 2014 ... will host recruit757’s scholarship workshop for football players ... on Tuesday, Sept. 23. , Doors open at 6:30 ... Performance Center and speak to trainers and physical therapists. ... until 9 p.m. , The Newport News Tidewater Performance ...
(Date:9/17/2014)... 2014 (HealthDay News) -- A blood test that measures ... with a better assessment of the state of a ... used routinely, this blood test could reveal when ... begins promoting tumor growth, the researchers suggested. "Our ... with advanced prostate cancer and often initially very effective ...
Breaking Medicine News(10 mins):Health News:Chromosome buffers hold key to better melanoma understanding 2Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 2Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 3Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 4Health News:Transvaginal Mesh Lawsuit News: New Order in C.R. Bard MDL Sets Schedule of Conferences for September to December, the Rottenstein Law Group LLP Reports 2Health News:Tidewater Physical Therapy and Performance Services and recruit757 To Host Football Scholarship Seminar 2Health News:Tidewater Physical Therapy and Performance Services and recruit757 To Host Football Scholarship Seminar 3Health News:DNA Blood Test Might Identify Status of Prostate Cancer 2
... ... literature on the medical step-by-step process of Gastric Banding and Roux-en-Y Gastric Banding ... ... weight gain, Western Bariatric Institute, a leader in Bariatric surgery since 2000, is ...
... ... increase the comfort and value of their homes while reducing their gas bill at the ... to $1,500 for energy efficient improvements for items like insulation, water heaters, furnaces and boilers. ... Rolling Meadows, IL ...
... receives The Help Group Champion for Children Award , ... 2009 - Advances and Best Practices in Autism, Learning Disabilities ... Saturday, October 3rd at The Skirball Cultural Center in Los ... experts from across the country. Generously sponsored by First ...
... Nick Buoniconti and his son Marc hosted ... Great Sports Legends Dinner, held at the Waldorf=Astoria, ... joined by sports legends, philanthropic heroes and business leaders ... Great Sports Legend honorees were Troy Aikman, Clyde Drexler, Mike ...
... ... a press briefing session on "Personalized Medicine and the Future of Health Care Practice" at ... ... (ASHG) will be hosting a press briefing session on "Personalized Medicine and the Future of ...
... for Cardiothoracic Surgery have performed countless successful Lung ... diagnosis of lung cancer can be a daunting one. Swift, ... than any other type of cancer, lung cancer is indeed ... to health, a number of different treatments are considered. The ...
Cached Medicine News:Health News:Making Weight Loss Surgery Safer and More Effective 2Health News:Energy360 Solutions Ramps up to Handle Demand of Chicagoland Natural Gas Savings Program 2Health News:Energy360 Solutions Ramps up to Handle Demand of Chicagoland Natural Gas Savings Program 3Health News:The Help Group Summit on Autism, Learning Disabilities, and ADHD Features State-of-the-Art Research and Best Practices in Education and Treatment 2Health News:The Help Group Summit on Autism, Learning Disabilities, and ADHD Features State-of-the-Art Research and Best Practices in Education and Treatment 3Health News:The Help Group Summit on Autism, Learning Disabilities, and ADHD Features State-of-the-Art Research and Best Practices in Education and Treatment 4Health News:The 24th Annual Great Sports Legends Dinner Raises More Than $6.3 Million for the Buoniconti Fund to Cure Paralysis 2Health News:The 24th Annual Great Sports Legends Dinner Raises More Than $6.3 Million for the Buoniconti Fund to Cure Paralysis 3Health News:The American Society of Human Genetics to Host Press Briefing on 'Personalized Medicine and the Future of Health Care Practice' at 59th Annual Meeting 2Health News:The American Society of Human Genetics to Host Press Briefing on 'Personalized Medicine and the Future of Health Care Practice' at 59th Annual Meeting 3Health News:The American Society of Human Genetics to Host Press Briefing on 'Personalized Medicine and the Future of Health Care Practice' at 59th Annual Meeting 4Health News:The California Center for Cardiothoracic Surgery (heart411.com) Surgeons are Leaders in Lung Cancer Surgery 2
This 100 µL is the equivalent to the "Universal Blue" tips and fits virtually every manufacturer's 1000 µL Pipettor....
Conducting disposable tips provide cross-contaminationfree pipetting for sensitive applications such as PCR setup....
Volume range 0.2-10 l. Designed for pipetting micro-sized drops. Ideal for use with micro volume Finnpipettes....
Conducting disposable tips....
Medicine Products: